Inside BRI's Down Syndrome Biorepository
Read Article
Could GLP-1RA Medications Help Treat Type 1 Diabetes
Sarah Kobernat, PhD, is working to find out.
Behind BRI's Biorepositories: How they started and continue to fuel discoveries
Learn how our biorepositories power life-changing breakthroughs.
Remembering Becky Benaroya: A Legacy of Generosity and Support for Science
Benaroya Research Institute honors and remembers (“Becky”) Benaroya, a beloved member of our community whose generosity, compassion and commitment to improving lives leaves a remarkable impact.
Weathering Uncertainty with Resilience
Read recent highlights and learn what’s on the horizon in 2026 from BRI President Jane Buckner, MD.
From Bootstrap Operation to Nobel Prize
Learn the backstory of a discovery that changed our understanding of the immune system and earned a Nobel Prize from Steven Ziegler, PhD.
Understanding the Immune System’s Brakes
Explore work from Daniel Campbell, PhD, examining how a cytokine called IL2 could lead to new therapies for autoimmune diseases.
A Decades-Long Dream Becomes Reality
Learn how research led by Jane Buckner, MD, is bringing regulatory T cell-based therapies closer to clinical trials.
“Keep Asking the Next Question:” Lessons Rhodes Scholar Shubham Bansal Learned at BRI
Learn more about how his time at BRI helped shape 2025 Rhodes Scholar Shubham Bansal.
Mapping Immune Cells in the Skin
Learn how Peter Morawski, PhD, and Hannah DeBerg, PhD, are mapping immune cells in the skin to better understand how they may fight — or fuel — disease.
Innovation Fund Backs Exciting New Research
Allyson Byrd, PhD, and Cate Speake, PhD, are exploring an innovative tool in immunology research. The questions they can ask are limitless.